A B S T R A C T We studied the effects of vitamin
INTRODUCTION
WVihile much is known about the independent actions of the two principal regulators of mammaliani calcium homeostasis, parathyroid hormiione (PTH)', and the most active metabolite of vitaimiin (1D3), 1,25-dihydroxycholecalciferol 1,25-(OH)2D3, limited information exists about their interrelationships (1) . It has been known for many years that vitamin D is re(quired for PTH to exert its full biologic actioni; in raclhitic animals, the calcemic response to injected PTH is greatly blunted (1, 2) . Recently, the coniverse of the interrelationship has been proposed: PTH stimulaltes coniversion of 25-hydroxycholecalciferol, 25 -(OH)D3, to 1,25-(OH)2D3 in the kidney (3) (4) (5) .
Previous work has established the existenice of a metabolic pathway for conversioni of D3, first by the liver to 25-(OH)D3, anid then by the kidney to 1,25-(OH)2D3, or 24,25-dihydroxycholecalciferol (24, 25 -(OH)2D3) (6) (7) (8) (9) . The biologically most active formn of D3, 1,25-(OH)2D3 initiates the biological response of increased calcium absorption in the target tissues, intestine, and bone. The biologic funicetionis of 24,25-(OH)2D3 remain to be elucidated. (OH)2D3 in parathyroid glands has been reported (11, 12) , and (c) simultaneous administration of 1,25-(OH)2D3 and 24,25-(OH)2D3, but not their separate administration, mediate a reduction of parathyroid gland weight and DNA content in rachitic chicks independent of any effects on serum calcium (13) . In addition, calcium binding protein, similar to the one which is D-dependent and found in intestinal mucosa, has been reported to be present in porcine parathyroid glands (14) .
Recently, more direct experiments to examine the influence of vitamin D on PTH secretion have been reported. Shen (18) . In all of these studies, PTH secretion was assessed by measurement of immunoreactive parathyroid hormone (iPTH) in the peripheral circulation.
Care and colleagues (19) 24,25- (OH)2D3.
METHODS
The surgical procedures employed will he described in detail elsewhere (20) . In brief, mongrel dogs of both sexes weighing 15-20 kg were anesthetized with sodium pentobarbital, and catheters for blood sampling were placed into the right inferior thyroid vein and into a femoral vein. Injections of test materials were given directly into or near the cranial thyroid artery. In early experiments, it proved technically difficult to inject directly into the thyroid artery. Therefore materials were injected into the carotid artery just below the cranial thyroid artery while briefly clampinig the carotid above it. In later experiments it was possible to cannulate the thyroid artery directly. Results obtained by these two procedures were indistinguishable. An advantage of using the dog for the study of PTH secretion is that in this species both parathyroid glands of one side of the neck drain predominantly into a single thyroidl veini.
Blood samples for serum iPTH and calcium determinilations were taken simultaneously from the femoral and inferior thyroid veins for a minimum of three base line samples, taken at 5-10-min intervals before injection of test material. Thereafter, the samples were taken from both sides every 5 min for the first 60 min and then every 15 min for 2-4 h.
The vitamin D metabolites used were chemiiically svnithetized and crystalline. Upon analysis they exhibited typical ultraviolet spectra at 264 nM for vitamin D compoutnds. Each metabolite yielded a single component on Sephadex LH-20 (Pharmacia Fine Chemicals, Pharmacia, Inc., Piscataway, N. J.) and high pressure liquid chromatography.
Antiserum CH-71 at a final dilution of 1:125,000 was used for all iPTH measurements. This antiserumil cross-reacts with intact hormone as well as NH2-and COOH-ternuinal fragments (21) (22) (23) . For phase separations, the dextrani-coated charcoal method as described by Arnaud et al. was used (24) . All samples were measured in duplicate at two widely varying dilutions. The coefficient of variation of replicates was 9%; assays showing a larger variation were repeated. iPTH levels reported are in arbitrary units (,ul eq/ml), relating the potency of the test serum to that of a standard hyperparathyroid serum which was assigned a potency of 1,000 ,geq-/ml.
The standard serum was obtained from a dog with experimentally induced chronic renal failure (25) . Serum calcium was measured on fresh samples by flame emission spectrophotometry; in some experiments, ionized calcium was 
RESULTS

Control experiments
Vitamin D3 and its metabolites were suspended in a vehicle of ethanol. Injection of this vehicle into the thyroid artery caused no changes in any of the parameters measured (Fig. 1 ). Further control experiments using native vitamin D3 in large doses showed that the unaltered vitamin had no effect, the results being identical with those obtained with ethanol alone. In three experiments, vitamin D was infused in the dose of 250 ng. In two additional experiments the dose was 1,250 ng.
The model was very stable. Fluctuations in PTH secretion probably represent small bursts of secretion previously suggested by Deftos et al. (26) . In all experiments, the concentration of iPTH in the thyroid venous effluent was 2-4 times higher than in the peripheral venous circulation. Such a gradient has been demonstrated in man at sites of hyperfunctioning para- [24] [25] [26] [27] [28] [29] [30] min. In the lowest dose tested, 5 ng, this metabolite had no effect. The characteristic pattern of response is illustrated in Fig. 3 In all experiments except the one identified, vitamin D metabolites were administered as a single bolus of 0.2 ml into the superior thyroid artery. In the injections into the femoral vein, the volume of injection was 1.5 ml. NC, no change.
* PTH levels are given as ,ul eq/ml. The range for normal dog peripheral samples is 70-95. (41) . The steroid-receptor complex then initiates a synthesis of specific messenger RNA molecules (42, 43) which, in turn, code for biosynthesis of specific proteins related to biologic response of that steroid (44, 45) . The extraordinary rapidity of onset of response observed renders the accepted mechanism of action of steroid hormone highly unlikely in these experiments.
Despite the uncertainties concerning effective doses, our observations suggest important clinical implications. For example, it is possible that, in the genesis of hyperparathyroidism, the problem resides less in the continued stimulation of PTH secretion by some known or unknown secretogogues, but rather in the failure of dampening signals to become effective. The experi-
